<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03446365</url>
  </required_header>
  <id_info>
    <org_study_id>1R01MD012225-01</org_study_id>
    <nct_id>NCT03446365</nct_id>
  </id_info>
  <brief_title>Peer-Administered Asthma Self-Management Intervention in Urban Middle Schools</brief_title>
  <acronym>PeerASMAS</acronym>
  <official_title>Peer-Administered Asthma Self-Management Intervention in Urban Middle Schools</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rhode Island Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Puerto Rico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rhode Island Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Health disparities in pediatric asthma persist, with Latino children demonstrating increased
      asthma morbidity. Middle school children with asthma have greater morbidity than children
      from any other age group and spend a majority of their day in school, where they must manage
      any asthma. The investigators developed and piloted a novel group-based intervention - ASMAS
      (Asthma Self-MAnagement in Schools) in two geographic areas with a high prevalence of urban
      and Latino children with asthma: Providence, Rhode Island, and San Juan, Puerto Rico. ASMAS
      is a 4-session, peer-facilitated asthma self-management intervention specific to the school
      setting for Latino middle school (6th-8th graders) children. It is delivered by trained High
      School Juniors and Seniors of Latino descent with asthma. The preliminary effects of ASMAS
      for improving asthma outcomes and self-management relative to controls were demonstrated in a
      previous intervention development study. This study will evaluate ASMAS through a
      large-scaled Randomized Control Trial with urban middle school students who have persistent
      asthma in Providence, Rhode Island and San Juan, Puerto Rico and will identify barriers and
      facilitators to the implementation of ASMAS. These results will inform future, large-scale
      dissemination in other urban school settings.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of this study is to evaluate a 4-session, peer-facilitated asthma self-management
      intervention for Latino, middle school (6th-8th) youth in urban public school settings. The
      intervention, ASMAS (Asthma Self-Management in Schools) is administered by trained and
      supervised High School juniors and seniors of Latino descent with asthma to middle school
      peers with asthma. This study is a partnership with a second research group in San Juan,
      Puerto Rico, since there is also a high rate of asthma in children there.

      There are 2 goals in this study. The first goal is to evaluate the effects of ASMAS on asthma
      health outcomes (for example, asthma control, symptom free days, school absences and lung
      function) and on asthma self-management (skills, knowledge and self-efficacy, availability of
      rescue inhaler and action plan at school) in a sample of 432 Latino middle school children
      with asthma in Providence, Rhode Island and San Juan, Puerto Rico.

      Middle schoolers and a primary caregiver will complete a baseline research session, as well
      as, immediately post intervention and 4-month, 8-month and 12-month post intervention
      follow-up research home visits during which they will complete study questionnaires about the
      child's asthma. Students will be randomly assigned to one of three study groups. Assignment
      is random (like a coin toss), and what each student does in school depends on what group each
      student is assigned to. The ASMAS group and the Asthma + Health Education groups will learn
      about asthma and about other selected health topics during their in-school intervention
      sessions (1 per week for 4 weeks). The &quot;no treatment&quot; study group will not attend in-school
      group sessions at all.

      The second goal in the study is to evaluate the intervention in preparation for using it on a
      wider scale in other places. Students, caregivers, High School Peers, school administrators
      and additional community members will be invited to participate in group discussions about
      the intervention.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2018</start_date>
  <completion_date type="Anticipated">August 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>6th to 8th grade middle schoolers will be enrolled then randomly assigned to one of three conditions: 1) ASMAS, 6th to 8th grade middle schoolers will be enrolled then randomly assigned to 1) ASMAS, or 2) Asthma Education plus Child Health control condition, or 3) a no treatment control condition</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in asthma control</measure>
    <time_frame>Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention</time_frame>
    <description>Assessed by child and parent report through the 7-item Child Asthma Control Test (C-ACT)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in symptom free days</measure>
    <time_frame>Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention</time_frame>
    <description>By parent report using standard questionnaire of symptom-free days/nights in prior 30 days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in asthma related school absence ratio</measure>
    <time_frame>Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention</time_frame>
    <description>Asthma related school absence ratio will be calculated from school attendance data and caregiver report of school absences due to asthma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in lung function</measure>
    <time_frame>Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention</time_frame>
    <description>The Asthma Monitor 2 (AM2, ERT, USA) is a hand-held, computerized spirometer that collects pulmonary function indexes (Forced Expiratory Volume at one second, FEV1 ). Children will use AM2 during one week using standard procedures, 2x/day (before medications AM/PM). FEV1 predicted will be obtained.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in child asthma knowledge</measure>
    <time_frame>Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention</time_frame>
    <description>Child report through the valid and reliable Asthma Knowledge Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in child asthma self-efficacy</measure>
    <time_frame>Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention</time_frame>
    <description>Child report through valid and reliable children's Asthma Self-Efficacy Scale (Cronbach alpha .87; Bursch, et al, 1999). The scale includes 14 items with responses ranging from 1 to 6, and higher scores indicate more self-efficacy to care for asthma. An asthma self-efficacy score is calculated using the average of the 14 items.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in asthma self-management</measure>
    <time_frame>Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention</time_frame>
    <description>Through a well-validated and reliable measure; child and caregiver versions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in asthma Action plan/Inhaler availability</measure>
    <time_frame>Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention</time_frame>
    <description>School Nurse report of Availability of rescue inhaler at school and asthma action plan with school nurse</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">432</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>ASMAS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ASMAS is an asthma self-management program based on NHLBI clinical guidelines for optimal school-based asthma management. It involves 4, 1Â½ hour sessions delivered in group format in the urban, middle school setting by a Latino High School Peer who has asthma. ASMAS focuses on asthma pathophysiology, symptom management, asthma medications, and trigger control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Asthma education plus child health</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Asthma Education plus Child Health control condition will be delivered by an adult Health Educator , and includes 4 sessions (1 1/2 hrs long) of our existing asthma education (&quot;Asthma's Magic Number&quot;) with added general health topics (nutrition, physical activity, safety).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Treatment Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Students randomly assigned to this arm , will receive standard of care, which is no treatment, and will not participate in any group intervention sessions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ASMAS</intervention_name>
    <description>A high school peer led group intervention for middles school students targeting asthma education and asthma management practices.</description>
    <arm_group_label>ASMAS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Asthma education plus child health</intervention_name>
    <description>Health educator led intervention focused on asthma education and other child health topics.</description>
    <arm_group_label>Asthma education plus child health</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria specify that students must:

          -  Be 11-14 years old

          -  Attend 6th, 7th or 8th grade

          -  attend a targeted public school

          -  have physician-diagnosed asthma according to caregiver and provider report

          -  meet criteria for current persistent asthma either by a) having a current prescription
             for an asthma controller medicine, or b) having any of the following in the previous 4
             weeks:

        I. daytime asthma symptoms &gt; 2 days/week,

        II. nighttime awakenings due to asthma at least 3-4 times/month,

        III. short-acting beta agonist use at least 2 days/week,

        IV. activity limitation, or

        V. oral steroid use at least 2 times/year

          -  children must have recent active asthma activity in the previous 4 weeks through
             endorsement of any of criteria I-V above

          -  In Rhode Island, children's primary caregiver must identify as Latino

          -  In Rhode Island, children must speak English

        Exclusion criteria:

          -  active immunotherapy,

          -  other pulmonary disease,

          -  receiving special education services in a self-contained classroom,

          -  any severe psychiatric or medical conditions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daphne Koinis-Mitchell, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rhode Island Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Glorisa Canino, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Puerto Rico</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria T Coutinho, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Rhode Island Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daphne Koinis-Mitchell, PhD</last_name>
    <phone>(401) 793-3682</phone>
    <email>dkoinismitchell@lifespan.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria T Coutinho, PhD</last_name>
    <phone>(401) 793-8860</phone>
    <email>mcoutinho@lifespan.org</email>
  </overall_contact_backup>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 24, 2018</study_first_submitted>
  <study_first_submitted_qc>February 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2018</study_first_posted>
  <last_update_submitted>February 26, 2018</last_update_submitted>
  <last_update_submitted_qc>February 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Latino children</keyword>
  <keyword>middle school</keyword>
  <keyword>peer models</keyword>
  <keyword>educational intervention</keyword>
  <keyword>high school students</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

